University Hospital, Ghent: Psoriasis trials
The registry lists 12 Psoriasis studies with University Hospital, Ghent as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 4 8No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS)RecruitingNCT05685940Phase 4
- Therapeutic Drug Monitoring of Tildrakizumab in Psoriasis PatientsRecruitingNCT05683015Phase 4
- Value Based Healthcare in PsoriasisRecruitingNCT05480917Not applicable
- Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO)RecruitingNCT04080635Not applicable
- A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients Who Are OvertreatedCompletedNCT05683054Phase 4
- Modified Intermittent Fasting in PsoriasisCompletedNCT04418791Not applicable
- Therapeutic Drug Monitoring of Ixekizumab in Psoriasis PatientsCompletedNCT04083612Phase 4
- Therapeutic Drug Monitoring of Secukinumab in Psoriasis Patients.CompletedNCT04080661Phase 4
- Therapeutic Drug Monitoring of Guselkumab in Psoriasis PatientsCompletedNCT04080648Phase 4
- Dose Tapering Study of Adalimumab in PsoriasisTerminatedNCT04028713Phase 4
- Therapeutic Drug Monitoring of Adalimumab in Psoriasis PatientsCompletedNCT02147600
- Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic DermatitisCompletedNCT01077882Phase 4